Syros Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (12)

Latest Posts

About This Stock More About This Stock
Top ETF Of December & Its Best Stocks
Article By: Sweta Killa
Thursday, December 24, 2020 4:58 PM EDT
Although most of the stocks in the ARKG fund’s portfolio delivered strong returns, a few gained at least 80% last month. Here are the five best-performing stocks in the ETF with their respective positions in the basket.
In this article: BEAM, PACB, EDIT, SYRS, AQB Also: ARKG
Read
Stock Charts To Watch - Tuesday, January 7
Video By: Harry Boxer
Tuesday, January 7, 2020 8:00 PM EDT
Apache Corporation was up 6.87, or 27%, to 32.51, closing just pennies off the 32.58 high, on 36.5 million shares on Tuesday.
In this video: APA, PERI, INMD, BYND, SPNS, SYRS
Watch
Syros Announces Strategic Priorities, Milestones Ahead Of JPMorgan Conference
Article By: The Fly
Sunday, January 6, 2019 3:00 AM EDT
Syros Pharmaceuticals outlined its strategic priorities and expected upcoming milestones.
In this article: SYRS
Read
Premarket Biotech Digest – CBMG Inks New Deal, IPCI Sued, SYRS Gets FDA Nod
Article By: KKD Healthcare Analytics
Tuesday, April 11, 2017 9:34 AM EDT
Geron Corporation stock picked up on the news that the company has agreed to a settlement related to a consolidated class-action securities lawsuit. The company stock jumped over 19 percent in its previous trading session.
In this article: TXMD, GERN, IPCI, RPRX, GBLX, OMED, CBMG, SYRS
Read
Syros Pharmaceuticals: Despite High-Demand Treatments, We Remain Cautious
Article By: Don Dion
Wednesday, July 6, 2016 9:17 PM EDT
Based in Watertown, Massachusetts, Syros Pharmaceuticals is a biopharmaceutical company that is developing treatments to control genes in patients with cancer, immune-mediated diseases, and other illnesses.
In this article: NVS, AGIO, KPTI, SYRS
Read

Latest Tweets for $SYRS

No tweets yet!